These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27422621)

  • 1. OpenGeneMed: a portable, flexible and customizable informatics hub for the coordination of next-generation sequencing studies in support of precision medicine trials.
    Palmisano A; Zhao Y; Li MC; Polley EC; Simon RM
    Brief Bioinform; 2017 Sep; 18(5):723-734. PubMed ID: 27422621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GeneMed: An Informatics Hub for the Coordination of Next-Generation Sequencing Studies that Support Precision Oncology Clinical Trials.
    Zhao Y; Polley EC; Li MC; Lih CJ; Palmisano A; Sims DJ; Rubinstein LV; Conley BA; Chen AP; Williams PM; Kummar S; Doroshow JH; Simon RM
    Cancer Inform; 2015; 14(Suppl 2):45-55. PubMed ID: 25861217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
    Coyne GO; Takebe N; Chen AP
    Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. svist4get: a simple visualization tool for genomic tracks from sequencing experiments.
    Egorov AA; Sakharova EA; Anisimova AS; Dmitriev SE; Gladyshev VN; Kulakovskiy IV
    BMC Bioinformatics; 2019 Mar; 20(1):113. PubMed ID: 30841857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMITH: a LIMS for handling next-generation sequencing workflows.
    Venco F; Vaskin Y; Ceol A; Muller H
    BMC Bioinformatics; 2014; 15 Suppl 14(Suppl 14):S3. PubMed ID: 25471934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The possibility of clinical sequencing in the management of cancer.
    Kou T; Kanai M; Matsumoto S; Okuno Y; Muto M
    Jpn J Clin Oncol; 2016 May; 46(5):399-406. PubMed ID: 26917600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer Program.
    Mantripragada KC; Olszewski AJ; Schumacher A; Perez K; Birnbaum A; Reagan JL; Mega A; Khurshid H; Bartley C; Lombardo A; Rossiter R; Papa A; Bakalarski P; Safran H
    J Oncol Pract; 2016 Apr; 12(4):e396-404. PubMed ID: 26907448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomics-Enabled Precision Medicine for Cancer.
    Roos A; Byron SA
    Cancer Treat Res; 2019; 178():137-169. PubMed ID: 31209844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enabling precision medicine via standard communication of HTS provenance, analysis, and results.
    Alterovitz G; Dean D; Goble C; Crusoe MR; Soiland-Reyes S; Bell A; Hayes A; Suresh A; Purkayastha A; King CH; Taylor D; Johanson E; Thompson EE; Donaldson E; Morizono H; Tsang H; Vora JK; Goecks J; Yao J; Almeida JS; Keeney J; Addepalli K; Krampis K; Smith KM; Guo L; Walderhaug M; Schito M; Ezewudo M; Guimera N; Walsh P; Kahsay R; Gottipati S; Rodwell TC; Bloom T; Lai Y; Simonyan V; Mazumder R
    PLoS Biol; 2018 Dec; 16(12):e3000099. PubMed ID: 30596645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D3Oncoprint: Stand-Alone Software to Visualize and Dynamically Explore Annotated Genomic Mutation Files.
    Palmisano A; Zhao Y; Simon RM
    JCO Clin Cancer Inform; 2018 Dec; 2():1-9. PubMed ID: 30652557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing.
    Patel NM; Michelini VV; Snell JM; Balu S; Hoyle AP; Parker JS; Hayward MC; Eberhard DA; Salazar AH; McNeillie P; Xu J; Huettner CS; Koyama T; Utro F; Rhrissorrakrai K; Norel R; Bilal E; Royyuru A; Parida L; Earp HS; Grilley-Olson JE; Hayes DN; Harvey SJ; Sharpless NE; Kim WY
    Oncologist; 2018 Feb; 23(2):179-185. PubMed ID: 29158372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.
    Perera-Bel J; Hutter B; Heining C; Bleckmann A; Fröhlich M; Fröhling S; Glimm H; Brors B; Beißbarth T
    Genome Med; 2018 Mar; 10(1):18. PubMed ID: 29544535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WHATIF: An open-source desktop application for extraction and management of the incidental findings from next-generation sequencing variant data.
    Ye Z; Kadolph C; Strenn R; Wall D; McPherson E; Lin S
    Comput Biol Med; 2016 Jan; 68():165-9. PubMed ID: 25890833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial.
    Lih CJ; Sims DJ; Harrington RD; Polley EC; Zhao Y; Mehaffey MG; Forbes TD; Das B; Walsh WD; Datta V; Harper KN; Bouk CH; Rubinstein LV; Simon RM; Conley BA; Chen AP; Kummar S; Doroshow JH; Williams PM
    J Mol Diagn; 2016 Jan; 18(1):51-67. PubMed ID: 26602013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation sequencing: from conventional applications to breakthrough genomic analyses and precision oncology.
    Ziogas DE; Kyrochristos ID; Roukos DH
    Expert Rev Med Devices; 2018 Jan; 15(1):1-3. PubMed ID: 29284319
    [No Abstract]   [Full Text] [Related]  

  • 17. DIVIS: Integrated and Customizable Pipeline for Cancer Genome Sequencing Analysis and Interpretation.
    He X; Zhang Y; Yuan D; Han X; He J; Duan X; Liu S; Wang X; Niu B
    Front Oncol; 2021; 11():672597. PubMed ID: 34168993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations of developing an NGS assay for clinical applications in precision oncology: The NCI-MATCH NGS assay experience.
    Lih CJ; Takebe N
    Curr Probl Cancer; 2017; 41(3):201-211. PubMed ID: 28625332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
    Syn NL; Yong WP; Goh BC; Lee SC
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized Oncology Suite: integrating next-generation sequencing data and whole-slide bioimages.
    Dander A; Baldauf M; Sperk M; Pabinger S; Hiltpolt B; Trajanoski Z
    BMC Bioinformatics; 2014 Sep; 15(1):306. PubMed ID: 25230706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.